Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Cash on Hand 2020–2023
Immuneering Corporation annual cash on hand history from 2020 to 2023. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Immuneering Corporation cash on hand as of December 31, 2023: 59.4M, a 18.22% decrease year-over-year.
- Immuneering Corporation cash on hand for 2023 were 59.4M, a 18.22% decrease from 2022.
- Immuneering Corporation cash on hand for 2022 were 72.6M, a 3.01% decrease from 2021.
- Immuneering Corporation cash on hand for 2021 were 74.9M, a 101.91% increase from 2020.
- Immuneering Corporation cash on hand for 2020 were 37.1M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Immuneering Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2023 | $59 |
| 2022 | $73 |
| 2021 | $75 |
| 2020 | $37 |
Immuneering Corporation Cash on Hand — FAQ
Immuneering Corporation (IMRX) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's cash on hand history?
The chart and table above show Immuneering Corporation's cash on hand by year and by quarter, including the growth rate.